Ara
Toplam kayıt 1, listelenen: 1-1
Ifosfamide, Idarubicin, And Etoposide In Relapsed/Refractory Hodgkin Disease Or Non-Hodgkin Lymphoma: A Salvage Regimen With High Response Rates Before Autologous Stem Cell Transplantation
(Elsevier Science Inc, 2005)
To achieve long-term disease-free survival, high-dose therapy and autologous stem cell transplantation (ASCT) is the current standard approach in patients with relapsed or refractory Hodgkin disease (HD) or non-Hodgkin ...